Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01783444
Brief Title: A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. (BOLERO-6)

First Submitted : January 11, 2013
First Submitted that Met QC Criteria : February 4, 2013
First Posted : February 5, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : February 27, 2019
Last Update Posted : March 1, 2019